Deception and manipulation: The arms of Leishmania, a successful parasite

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Cecílio, Pedro ^a   Pérez Cabezas, Begoña ^a   Santarém, Nuno ^a   Maciel, Joana ^a   Rodrigues, Vasco ^a   da Silva, Anabela Cordeiro ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Acquired immunity; Apoptosis; Immunomodulation; Innate immunity; Leishmania

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; NUCLEOSIDE DIPHOSPHATE KINASE; PHOSPHATIDYLSERINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTATION; APOPTOSIS; CELL DEATH; CELL INFILTRATION; CELL INVASION; CLONAL ANERGY; CYTOKINE PRODUCTION; CYTOLYSIS; DISEASE COURSE; EFFECTOR CELL; GLYCOCALYX; GRANULOCYTE; HOST PARASITE INTERACTION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOLYSOSOME; REVIEW; SIGNAL TRANSDUCTION;

EID: 84918800322     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00480     Document Type: Review

References (249)

1. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol (2007) 37(10):1097-106. doi: 10.1016/j.ijpara.2007.04.003
2. Beattie L, Kaye PM. Leishmania-host interactions: what has imaging taught us? Cell Microbiol (2011) 13(11):1659-67. doi:10.1111/j.1462-5822.2011.01658.x
3. Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 9(8):604-15. doi:10.1038/nrmicro2608
4. WHO. Control of Leishmaniasis: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis. WHO Technical Report Series n 949. Switzerland: Published by World Health Organization (2010).
5. Sinha PK, Pandey K, Bhattacharya SK. Diagnosis & management of Leishmania/HIV co-infection. Indian J Med Res (2005) 121(4):407-14.
6. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet (2005) 366(9496):1561-77. doi:10.1016/S0140-6736(05)67629-5
7. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis (2004) 27(5):305-18. doi:10.1016/j.cimid.2004.03.004
8. Antinori S, Schifanella L, Corbellino M. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis (2012) 31(2):109-18. doi:10.1007/s10096-011-1276-0
9. Campino LMC. Epidemiologia das leishmanioses em Portugal. Acta Med Port (2010) 23:859-64.
10. Salman SM, Rubeiz NG, Kibbi AG. Cutaneous leishmaniasis: clinical features and diagnosis. Clin Dermatol (1999) 17(3):291-6. doi:10.1016/S0738-081X(99)00047-4
11. Kroidl A, Kroidl I, Bretzel G, Loscher T. Non-healing old world cutaneous leishmaniasis caused by L. infantum in a patient from Spain. BMC Infect Dis (2014) 14:206. doi:10.1186/1471-2334-14-206
12. Strazzulla A, Cocuzza S, Pinzone MR, Postorino MC, Cosentino S, Serra A, et al. Mucosal leishmaniasis: an underestimated presentation of a neglected disease. Biomed Res Int (2013) 2013:805108. doi:10.1155/2013/805108
13. Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol (2014) 6:147-54. doi:10.2147/CLEP.S44267
14. Okwor I, Uzonna JE. The immunology of Leishmania/HIV co-infection. Immunol Res (2013) 56(1):163-71. doi:10.1007/s12026-013-8389-8
15. Moreno J, Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol (2002) 18(9):399-405. doi:10.1016/S1471-4922(02)02347-4
16. Evans KJ, Kedzierski L. Development of vaccines against visceral Leishmaniasis. Re Dai Yi Xue Za Zhi (2012) 2012:892817. doi:10.1155/2012/892817
17. Stockdale L, Newton R. A review of preventative methods against human leishmaniasis infection. PLoS Negl Trop Dis (2013) 7(6):e2278. doi:10.1371/journal.pntd.0002278
18. van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 10(3):184-94. doi:10.1016/S1473-3099(10)70011-6
19. Yasinzai M, Khan M, Nadhman A, Shahnaz G. Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Fut Med Chem (2013) 5(15):1877-88. doi:10.4155/fmc.13.143
20. Feig C, Peter ME. How apoptosis got the immune system in shape. Eur J Immunol (2007) 37(Suppl 1):S61-70. doi:10.1002/eji.200737462
21. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell (1987) 49(2):273-80. doi:10.1016/0092-8674(87)90568-X
22. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med (1995) 181(1):71-7. doi:10.1084/jem.181.1.71
23. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (1995) 373(6513):438-41. doi:10.1038/373438a0
24. Mattner J, Donhauser N, Werner-Felmayer G, Bogdan C. NKT cells mediate organ-specific resistance against Leishmania major infection. Microbes Infect (2006) 8(2):354-62. doi:10.1016/j.micinf.2005.07.002
25. Kaczanowski S, Sajid M, Reece SE. Evolution of apoptosis-like programmed cell death in unicellular protozoan parasites. Parasit Vectors (2011) 4:44. doi:10.1186/1756-3305-4-44
26. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, Nakhasi HL. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ (2002) 9(1):53-64. doi:10.1038/sj.cdd.4400952
27. Proto WR, Coombs GH, Mottram JC. Cell death in parasitic protozoa: regulated or incidental? Nat Rev Microbiol (2013) 11(1):58-66. doi:10.1038/nrmicro2929
28. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M, et al. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci U S A (2006) 103(37):13837-42. doi:10.1073/pnas.0600843103
29. Wanderley JL, Pinto da Silva LH, Deolindo P, Soong L, Borges VM, Prates DB, et al. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One (2009) 4(5):e5733. doi:10.1371/journal.pone.0005733
30. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Investigat (1998) 101(4):890-8. doi:10.1172/JCI1112
31. Ravichandran KS. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med (2010) 207(9):1807-17. doi:10.1084/jem.20101157
32. Wanderley JL, Thorpe PE, Barcinski MA, Soong L. Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function. Parasite Immunol (2013) 35(3-4):109-19. doi:10.1111/pim.12019
33. van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun (2002) 70(8):4177-84. doi:10.1128/IAI.70.8.4177-4184.2002
34. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 321(5891):970-4. doi:10.1126/science.1159194
35. Ribeiro-Gomes FL, Peters NC, Debrabant A, Sacks DL. Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response. PLoS Pathog (2012) 8(2):e1002536. doi:10.1371/journal.ppat.1002536
36. Thalhofer CJ, Chen Y, Sudan B, Love-Homan L, Wilson ME. Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi. Infect Immun (2011) 79(1):108-17. doi:10.1128/IAI.00338-10
37. Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol (1992) 52(2):135-42.
38. Muller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, Solbach W, et al. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol (2001) 190(1-2):73-6. doi:10.1007/s004300100084
39. Pompeu ML, Freitas LA, Santos ML, Khouri M, Barral-Netto M. Granulocytes in the inflammatory process of BALB/c mice infected by Leishmania amazonensis. A quantitative approach. Acta Trop (1991) 48(3):185-93. doi:10.1016/0001-706X(91)90046-M
40. Hassani K, Shio MT, Martel C, Faubert D, Olivier M. Absence of metalloprotease GP63 alters the protein content of Leishmania exosomes. PLoS One (2014) 9(4):e95007. doi:10.1371/journal.pone.0095007
41. Matte C, Olivier M. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis (2002) 185(5):673-81. doi:10.1086/339260
42. Wilson ME, Innes DJ, Sousa AD, Pearson RD. Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol (1987) 73(1):55-63. doi:10.2307/3282344
43. Geering B, Simon HU. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ (2011) 18(9):1457-69. doi:10.1038/cdd.2011.75
44. Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, Muller K, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol (2002) 169(2):898-905. doi:10.4049/jimmunol.169.2.898
45. Allenbach C, Zufferey C, Perez C, Launois P, Mueller C, Tacchini-Cottier F. Macrophages induce neutrophil apoptosis through membrane TNF, a process amplified by Leishmania major. J Immunol (2006) 176(11):6656-64. doi:10.4049/jimmunol.176.11.6656
46. Santos-Beneit AM, Mollinedo F. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells. J Leukoc Biol (2000) 67(5):712-24.
47. Kilpatrick LE, Sun S, Mackie D, Baik F, Li H, Korchak HM. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2. J Leukoc Biol (2006) 80(6):1512-21. doi:10.1189/jlb.0406284
48. Sarkar A, Aga E, Bussmeyer U, Bhattacharyya A, Moller S, Hellberg L, et al. Infection of neutrophil granulocytes with Leishmania major activates ERK 1/2 and modulates multiple apoptotic pathways to inhibit apoptosis. Med Microbiol Immunol (2013) 202(1):25-35. doi:10.1007/s00430-012-0246-1
49. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev (2002) 13(6):455-81. doi:10.1016/S1359-6101(02)00045-X
50. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, et al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol (2004) 173(11):6521-5. doi:10.4049/jimmunol.173.11.6521
51. Filardy AA, Pires DR, Nunes MP, Takiya CM, Freire-de-Lima CG, Ribeiro-Gomes FL, et al. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J Immunol (2010) 185(4):2044-50. doi:10.4049/jimmunol.1000017
52. John B, Hunter CA. Immunology. Neutrophil soldiers or Trojan Horses? Science (2008) 321(5891):917-8. doi:10.1126/science.1162914
53. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, DosReis GA, Dutra AN, et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol (2008) 84(2):389-96. doi:10.1189/jlb.0108018
54. Ritter U, Frischknecht F, van Zandbergen G. Are neutrophils important host cells for Leishmania parasites? Trends Parasitol (2009) 25(11):505-10. doi:10.1016/j.pt.2009.08.003
55. Moore KJ, Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol (1994) 152(6):2930-7.
56. Ferrari D, Los M, Bauer MK, Vandenabeele P, Wesselborg S, Schulze-Osthoff K. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett (1999) 447(1):71-5. doi:10.1016/S0014-5793(99)00270-7
57. Hickman SE, el Khoury J, Greenberg S, Schieren I, Silverstein SC. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood (1994) 84(8):2452-6.
58. Kolli BK, Kostal J, Zaborina O, Chakrabarty AM, Chang KP. Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages. Mol Biochem Parasitol (2008) 158(2):163-75. doi:10.1016/j.molbiopara.2007.12.010
59. Kamir D, Zierow S, Leng L, Cho Y, Diaz Y, Griffith J, et al. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol (2008) 180(12):8250-61. doi:10.4049/jimmunol.180.12.8250
60. Akarid K, Arnoult D, Micic-Polianski J, Sif J, Estaquier J, Ameisen JC. Leishmania major-mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c. J Leukoc Biol (2004) 76(1):95-103. doi:10.1189/jlb.1001877
61. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 91(2):231-41. doi:10.1016/S0092-8674(00)80405-5
62. Ruhland A, Leal N, Kima PE. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol (2007) 9(1):84-96. doi:10.1111/j.1462-5822.2006.00769.x
63. Gutierrez-Kobeh L, de Oyarzabal E, Argueta J, Wilkins A, Salaiza N, Fernandez E, et al. Inhibition of dendritic cell apoptosis by Leishmania mexicana amastigotes. Parasitol Res (2013) 112(4):1755-62. doi:10.1007/s00436-013-3334-2
64. Valdes-Reyes L, Argueta J, Moran J, Salaiza N, Hernandez J, Berzunza M, et al. Leishmania mexicana: inhibition of camptothecin-induced apoptosis of monocyte-derived dendritic cells. Exp Parasitol (2009) 121(3):199-207. doi:10.1016/j.exppara.2008.10.020
65. Srivastav S, Basu Ball W, Gupta P, Giri J, Ukil A, Das PK. Leishmania donovani prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine signaling (SOCS) proteins. J Biol Chem (2014) 289(2):1092-105. doi:10.1074/jbc.M113.496323
66. Donovan MJ, Maciuba BZ, Mahan CE, McDowell MA. Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner. Exp Parasitol (2009) 123(1):58-64. doi:10.1016/j.exppara.2009.05.012
67. Lisi S, Sisto M, Acquafredda A, Spinelli R, Schiavone M, Mitolo V, et al. Infection with Leishmania infantum inhibits actinomycin d-induced apoptosis of human monocytic cell line U-937. J Eukaryot Microbiol (2005) 52(3):211-7. doi:10.1111/j.1550-7408.2005.00026.x
68. Real F, Florentino PT, Reis LC, Ramos-Sanchez EM, Veras PS, Goto H, et al. Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions. Cell Microbiol (2014). doi:10.1111/cmi.12311
69. de Lima VM, Fattori KR, de Souza F, Eugenio FR, dos Santos PS, Rozza DB, et al. Apoptosis in T lymphocytes from spleen tissue and peripheral blood of L. (L.) chagasi naturally infected dogs. Vet Parasitol (2012) 184(2-4):147-53. doi:10.1016/j.vetpar.2011.08.024
70. Moreira PR, Bandarra Mde B, Magalhaes GM, Munari DP, Machado GF, Prandini MM, et al. Influence of apoptosis on the cutaneous and peripheral lymph node inflammatory response in dogs with visceral leishmaniasis. Vet Parasitol (2013) 192(1-3):149-57. doi:10.1016/j.vetpar.2012.09.029
71. Bertho AL, Santiago MA, Da-Cruz AM, Coutinho SG. Detection of early apoptosis and cell death in T CD4+ and CD8+ cells from lesions of patients with localized cutaneous leishmaniasis. Braz J Med Biol Res (2000) 33(3):317-25. doi:10.1590/S0100-879X2000000300010
72. Potestio M, D'Agostino P, Romano GC, Milano S, Ferlazzo V, Aquino A, et al. CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis. Immunology (2004) 113(2):260-8. doi:10.1111/j.1365-2567.2004.01948.x
73. Das G, Vohra H, Saha B, Agrewala JN, Mishra GC. Leishmania donovani infection of a susceptible host results in apoptosis of Th1-like cells: rescue of anti-leishmanial CMI by providing Th1-specific bystander costimulation. Microbiol Immunol (1998) 42(11):795-801. doi:10.1111/j.1348-0421.1998.tb02354.x
74. Reckling S, Divanovic S, Karp CL, Wojciechowski S, Belkaid Y, Hildeman D. Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity. Infect Immun (2008) 76(3):1179-85. doi:10.1128/IAI.01093-06
75. Mukherjee P, Sen PC, Ghose AC. Lymph node cells from BALB/c mice with chronic visceral leishmaniasis exhibiting cellular anergy and apoptosis: involvement of Ser/Thr phosphatase. Apoptosis (2006) 11(11):2013-29. doi:10.1007/s10495-006-0088-7
76. Voth DE, Heinzen RA. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol (2007) 9(4):829-40. doi:10.1111/j.1462-5822.2007.00901.x
77. Sinai AP, Joiner KA. Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu Rev Microbiol (1997) 51:415-62. doi:10.1146/annurev.micro.51.1.415
78. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res (2010) 20(1):34-50. doi:10.1038/cr.2009.139
79. Naderer T, Vince JE, McConville MJ. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr Mol Med (2004) 4(6):649-65. doi:10.2174/1566524043360069
80. Joshi PB, Kelly BL, Kamhawi S, Sacks DL, McMaster WR. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol (2002) 120(1):33-40. doi:10.1016/S0166-6851(01)00432-7
81. Spath GF, Garraway LA, Turco SJ, Beverley SM. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci U S A (2003) 100(16):9536-41. doi:10.1073/pnas.1530604100
82. Spath GF, Lye LF, Segawa H, Sacks DL, Turco SJ, Beverley SM. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science (2003) 301(5637):1241-3. doi:10.1126/science.1087499
83. Puentes SM, Da Silva RP, Sacks DL, Hammer CH, Joiner KA. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol (1990) 145(12):4311-6.
84. McConville MJ, Turco SJ, Ferguson MA, Sacks DL. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J (1992) 11(10):3593-600.
85. Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang KP, Mosser DM. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol (1995) 155(6):3102-11.
86. Yao C, Gaur Dixit U, Barker JH, Teesch LM, Love-Homan L, Donelson JE, et al. Attenuation of Leishmania infantum chagasi metacyclic promastigotes by sterol depletion. Infect Immun (2013) 81(7):2507-17. doi:10.1128/IAI.00214-13
87. Dominguez M, Moreno I, Lopez-Trascasa M, Torano A. Complement interaction with trypanosomatid promastigotes in normal human serum. J Exp Med (2002) 195(4):451-9. doi:10.1084/jem.20011319
88. Moreno I, Dominguez M, Cabanes D, Aizpurua C, Torano A. Kinetic analysis of ex vivo human blood infection by Leishmania. PLoS Negl Trop Dis (2010) 4(7):e743. doi:10.1371/journal.pntd.0000743
89. Rizvi FS, Ouaissi MA, Marty B, Santoro F, Capron A. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur J Immunol (1988) 18(3):473-6. doi:10.1002/eji.1830180323
90. Blackwell JM, Ezekowitz RA, Roberts MB, Channon JY, Sim RB, Gordon S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 162(1):324-31. doi:10.1084/jem.162.1.324
91. Wilson ME, Pearson RD. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J Immunol (1986) 136(12):4681-8.
92. Brittingham A, Chen G, McGwire BS, Chang KP, Mosser DM. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun (1999) 67(9):4477-84.
93. Culley FJ, Harris RA, Kaye PM, McAdam KP, Raynes JG. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J Immunol (1996) 156(12):4691-6.
94. Talamas-Rohana P, Wright SD, Lennartz MR, Russell DG. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J Immunol (1990) 144(12):4817-24.
95. Ueno N, Bratt CL, Rodriguez NE, Wilson ME. Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes. Cell Microbiol (2009) 11(12):1827-41. doi:10.1111/j.1462-5822.2009.01374.x
96. Marth T, Kelsall BL. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 185(11):1987-95. doi:10.1084/jem.185.11.1987
97. Hawlisch H, Belkaid Y, Baelder R, Hildeman D, Gerard C, Kohl J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity (2005) 22(4):415-26. doi:10.1016/j.immuni.2005.02.006
98. Desjardins M, Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med (1997) 185(12):2061-8. doi:10.1084/jem.185.12.2061
99. Rodriguez NE, Gaur U, Wilson ME. Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol (2006) 8(7):1106-20. doi:10.1111/j.1462-5822.2006.00695.x
100. Duclos S, Desjardins M. Subversion of a young phagosome: the survival strategies of intracellular pathogens. Cell Microbiol (2000) 2(5):365-77. doi:10.1046/j.1462-5822.2000.00066.x
101. Forestier CL, Machu C, Loussert C, Pescher P, Spath GF. Imaging host cell-Leishmania interaction dynamics implicates parasite motility, lysosome recruitment, and host cell wounding in the infection process. Cell Host Microbe (2011) 9(4):319-30. doi:10.1016/j.chom.2011.03.011
102. Real F, Pouchelet M, Rabinovitch M. Leishmania (L.) amazonensis: fusion between parasitophorous vacuoles in infected bone-marrow derived mouse macrophages. Exp Parasitol (2008) 119(1):15-23. doi:10.1016/j.exppara.2007.12.013
103. Russell DG, Xu S, Chakraborty P. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J Cell Sci (1992) 103(Pt 4):1193-210.
104. Vinet AF, Fukuda M, Turco SJ, Descoteaux A. The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog (2009) 5(10):e1000628. doi:10.1371/journal.ppat.1000628
105. Holm A, Tejle K, Magnusson KE, Descoteaux A, Rasmusson B. Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: correlation with impaired translocation of PKCalpha and defective phagosome maturation. Cell Microbiol (2001) 3(7):439-47. doi:10.1046/j.1462-5822.2001.00127.x
106. Lodge R, Descoteaux A. Leishmania donovani promastigotes induce periphagosomal F-actin accumulation through retention of the GTPase Cdc42. Cell Microbiol (2005) 7(11):1647-58. doi:10.1111/j.1462-5822.2005.00582.x
107. Ganz T, Lehrer RI. Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today (1999) 5(7):292-7. doi:10.1016/S1357-4310(99)01490-2
108. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol (2010) 135(1):1-11. doi:10.1016/j.clim.2009.12.004
109. Kulkarni MM, McMaster WR, Kamysz E, Kamysz W, Engman DM, McGwire BS. The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol (2006) 62(5):1484-97. doi:10.1111/j.1365-2958.2006.05459.x
110. Kulkarni MM, McMaster WR, Kamysz W, McGwire BS. Antimicrobial peptide-induced apoptotic death of Leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 284(23):15496-504. doi:10.1074/jbc.M809079200
111. Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep (2013) 18(3):88-94. doi:10.1179/1351000213Y.0000000044
112. Murray HW, Nathan CF. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med (1999) 189(4):741-6. doi:10.1084/jem.189.4.741
113. Blos M, Schleicher U, Soares Rocha FJ, Meissner U, Rollinghoff M, Bogdan C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol (2003) 33(5):1224-34. doi:10.1002/eji.200323825
114. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 375(6530):408-11. doi:10.1038/375408a0
115. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol (1995) 25(4):1101-4. doi:10.1002/eji.1830250436
116. Boutard V, Havouis R, Fouqueray B, Philippe C, Moulinoux JP, Baud L. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J Immunol (1995) 155(4):2077-84.
117. Iniesta V, Gomez-Nieto LC, Molano I, Mohedano A, Carcelen J, Miron C, et al. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol (2002) 24(3):113-8. doi:10.1046/j.1365-3024.2002.00444.x
118. Buchmuller-Rouiller Y, Mauel J. Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and nonhealer mouse strains. J Immunol (1986) 136(10):3884-90.
119. McGwire B, Chang KP. Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol Biochem Parasitol (1994) 66(2):345-7. doi:10.1016/0166-6851(94)90160-0
120. Lodge R, Diallo TO, Descoteaux A. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell Microbiol (2006) 8(12):1922-31. doi:10.1111/j.1462-5822.2006.00758.x
121. Proudfoot L, Nikolaev AV, Feng GJ, Wei WQ, Ferguson MA, Brimacombe JS, et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci U S A (1996) 93(20):10984-9. doi:10.1073/pnas.93.20.10984
122. Tovar J, Cunningham ML, Smith AC, Croft SL, Fairlamb AH. Down- regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc Natl Acad Sci U S A (1998) 95(9):5311-6. doi:10.1073/pnas.95.9.5311
123. Sardar AH, Kumar S, Kumar A, Purkait B, Das S, Sen A, et al. Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses. J Proteomics (2013) 81:185-99. doi:10.1016/j.jprot.2013.01.011
124. Nare B, Garraway LA, Vickers TJ, Beverley SM. PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major. Curr Genet (2009) 55(3):287-99. doi:10.1007/s00294-009-0244-z
125. Ghosh S, Goswami S, Adhya S. Role of superoxide dismutase in survival of Leishmania within the macrophage. Biochem J (2003) 369(Pt 3):447-52. doi:10.1042/BJ20021684
126. Castro H, Sousa C, Santos M, Cordeiro-da-Silva A, Flohe L, Tomas AM. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic Biol Med (2002) 33(11):1552-62. doi:10.1016/S0891-5849(02)01089-4
127. Diaz-Gandarilla JA, Osorio-Trujillo C, Hernandez-Ramirez VI, Talamas-Rohana P. PPAR activation induces M1 macrophage polarization via cPLA(2)-COX-2 inhibition, activating ROS production against Leishmania mexicana. Biomed Res Int (2013) 2013:215283. doi:10.1155/2013/215283
128. Guler R, Afshar M, Arendse B, Parihar SP, Revaz-Breton M, Leitges M, et al. PKCdelta regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. Eur J Immunol (2011) 41(3):706-15. doi:10.1002/eji.201040985
129. Mia S, Warnecke A, Zhang XM, Malmstrom V, Harris RA. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol (2014) 79(5):305-14. doi:10.1111/sji.12162
130. Satoskar A, Bluethmann H, Alexander J. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun (1995) 63(12):4894-9.
131. Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, Rai M, et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis (2011) 204(7):1134-7. doi:10.1093/infdis/jir461
132. Nylen S, Gautam S. Immunological perspectives of leishmaniasis. J Global Infect Dis (2010) 2(2):135-46. doi:10.4103/0974-777X.62876 CrossRef Full Text Google Scholar
133. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev (2004) 201:206-24. doi:10.1111/j.0105-2896.2004.00190.x
134. Muraille E, Leo O. Revisiting the Th1/Th2 paradigm. Scand J Immunol (1998) 47(1):1-9. doi:10.1111/j.1365-3083.1998-47-1.00383.x
135. Ahmed S, Colmenares M, Soong L, Goldsmith-Pestana K, Munstermann L, Molina R, et al. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun (2003) 71(1):401-10. doi:10.1128/IAI.71.1.401-410.2003
136. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell (2006) 124(4):783-801. doi:10.1016/j.cell.2006.02.015 CrossRef Full Text Google Scholar
137. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol (2013) 13(8):551-65. doi:10.1038/nri3479
138. Liese J, Schleicher U, Bogdan C. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 37(12):3424-34. doi:10.1002/eji.200737182
139. Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 204(4):893-906. doi:10.1084/jem.20061293
140. Karmakar S, Bhaumik SK, Paul J, De T. TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis. PLoS Pathog (2012) 8(4):e1002646. doi:10.1371/journal.ppat.1002646
141. Paul J, Karmakar S, De T. TLR-mediated distinct IFN-gamma/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Eur J Immunol (2012) 42(8):2087-99. doi:10.1002/eji.201242428
142. Silvestre R, Silva AM, Cordeiro-da-Silva A, Ouaissi A. The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein. Immunology (2009) 128(4):484-99. doi:10.1111/j.1365-2567.2009.03132.x
143. Chandra D, Naik S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin Exp Immunol (2008) 154(2):224-34. doi:10.1111/j.1365-2249.2008.03741.x
144. Majumdar SB, Bhattacharya P, Bhattacharjee S, Majumder S, Banerjee S, Majumdar S. Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages. Indian J Exp Biol (2014) 52(1):17-29.
145. Srivastava S, Pandey SP, Jha MK, Chandel HS, Saha B. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. Clin Exp Immunol (2013) 172(3):403-9. doi:10.1111/cei.12074
146. Faria MS, Reis FC, Lima AP. Toll-like receptors in Leishmania infections: guardians or promoters? J Parasitol Res (2012) 2012:930257. doi:10.1155/2012/930257
147. Srivastav S, Kar S, Chande AG, Mukhopadhyaya R, Das PK. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response. J Immunol (2012) 189(2):924-34. doi:10.4049/jimmunol.1102845
148. Abu-Dayyeh I, Shio MT, Sato S, Akira S, Cousineau B, Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl Trop Dis (2008) 2(12):e305. doi:10.1371/journal.pntd.0000305
149. Gupta P, Giri J, Srivastav S, Chande AG, Mukhopadhyaya R, Das PK, et al. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response. FASEB J (2014) 28(4):1756-68. doi:10.1096/fj.13-238428
150. Xin L, Li K, Soong L. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol Immunol (2008) 45(12):3371-82. doi:10.1016/j.molimm.2008.04.018
151. Das S, Pandey K, Kumar A, Sardar AH, Purkait B, Kumar M, et al. TGF-beta1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20. Immunol Cell Biol (2012) 90(6):640-54. doi:10.1038/icb.2011.80
152. Shweash M, Adrienne McGachy H, Schroeder J, Neamatallah T, Bryant CE, Millington O, et al. Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. Mol Immunol (2011) 48(15-16):1800-8. doi:10.1016/j.molimm.2011.05.013
153. Faria MS, Calegari-Silva TC, de Carvalho Vivarini A, Mottram JC, Lopes UG, Lima AP. Role of protein kinase R in the killing of Leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNFalpha and IFNbeta. FASEB J (2014) 28:3050-63. doi:10.1096/fj.13-245126
154. Faria MS, Reis FC, Azevedo-Pereira RL, Morrison LS, Mottram JC, Lima AP. Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages. J Immunol (2011) 186(1):411-22. doi:10.4049/jimmunol.1002175
155. Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol (2006) 22(1):32-40. doi:10.1016/j.pt.2005.11.010
156. Antoniazi S, Price HP, Kropf P, Freudenberg MA, Galanos C, Smith DF, et al. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect Immun (2004) 72(9):5168-74. doi:10.1128/IAI.72.9.5168-5174.2004
157. Forget G, Matte C, Siminovitch KA, Rivest S, Pouliot P, Olivier M. Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur J Immunol (2005) 35(6):1906-17. doi:10.1002/eji.200526037
158. Kumar V, Bimal S, Singh SK, Chaudhary R, Das S, Lal C, et al. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Nutrition (2014) 30(4):449-58. doi:10.1016/j.nut.2013.10.003
159. Navas A, Vargas DA, Freudzon M, McMahon-Pratt D, Gore Saravia N, Gomez MA. Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite mediated induction of chemokine gene expression. Infect Immun (2014) 82(7):2872-80. doi:10.1128/IAI.01133-13
160. Kobets T, Havelkova H, Grekov I, Volkova V, Vojtiskova J, Slapnickova M, et al. Genetics of host response to Leishmania tropica in mice - different control of skin pathology, chemokine reaction, and invasion into spleen and liver. PLoS Negl Trop Dis (2012) 6(6):e1667. doi:10.1371/journal.pntd.0001667
161. Menezes-Souza D, Guerra-Sa R, Carneiro CM, Vitoriano-Souza J, Giunchetti RC, Teixeira-Carvalho A, et al. Higher expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 chemokines in the skin associated with parasite density in canine visceral leishmaniasis. PLoS Negl Trop Dis (2012) 6(4):e1566. doi:10.1371/journal.pntd.0001566
162. Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol (2001) 31(11):3185-96. doi:10.1002/1521-4141(200111)31:11<3185::AID-IMMU3185>3.0.CO;2-J
163. Katzman SD, Fowell DJ. Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. J Clin Invest (2008) 118(2):801-11. doi:10.1172/JCI33174
164. Roebrock K, Sunderkotter C, Munck NA, Wolf M, Nippe N, Barczyk K, et al. Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity. FASEB J (2014) 28(4):1724-34. doi:10.1096/fj.13-233593
165. Lazarski CA, Ford J, Katzman SD, Rosenberg AF, Fowell DJ. IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance. PLoS One (2013) 8(8):e71949. doi:10.1371/journal.pone.0071949
166. Ibrahim MK, Barnes JL, Osorio EY, Anstead GM, Jimenez F, Osterholzer JJ, et al. Deficiency of lymph node resident dendritic cells and dysregulation of DC chemoattractants in a malnourished mouse model of Leishmania donovani infection. Infect Immun (2014) 82(8):3098-112. doi:10.1128/IAI.01778-14
167. Ritter U, Moll H, Laskay T, Brocker E, Velazco O, Becker I, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis (1996) 173(3):699-709. doi:10.1093/infdis/173.3.699
168. Navas A, Vargas DA, Freudzon M, McMahon-Pratt D, Saravia NG, Gomez MA. Chronicity of dermal Leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression. Infect Immun (2014) 82(7):2872-80. doi:10.1128/IAI.01133-13
169. Teixeira MJ, Fernandes JD, Teixeira CR, Andrade BB, Pompeu ML, Santana da Silva J, et al. Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect Immun (2005) 73(2):1191-5. doi:10.1128/IAI.73.2.1191-1195.2005
170. Gorak PM, Engwerda CR, Kaye PM. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol (1998) 28(2):687-95. doi:10.1002/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N
171. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol (2009) 10(3):273-80. doi:10.1038/ni.1705
172. Srivastava N, Sudan R, Saha B. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection. J Immunol (2011) 186(10):5863-72. doi:10.4049/jimmunol.1003957
173. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, et al. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol (2004) 173(5):3297-304. doi:10.4049/jimmunol.173.5.3297
174. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med (1996) 183(2):515-26. doi:10.1084/jem.183.2.515
175. Belkaid Y, Butcher B, Sacks DL. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol (1998) 28(4):1389-400. doi:10.1002/(SICI)1521-4141(199804)28:04<1389::AID-IMMU1389>3.0.CO;2-1
176. Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity (2004) 21(5):643-53. doi:10.1016/j.immuni.2004.09.009
177. Ruhland A, Kima PE. Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol (2009) 122(1):28-36. doi:10.1016/j.exppara.2008.12.010
178. Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol (2002) 168(4):1627-35. doi:10.4049/jimmunol.168.4.1627
179. Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med (1997) 185(11):1977-85. doi:10.1084/jem.185.11.1977
180. Ashok D, Schuster S, Ronet C, Rosa M, Mack V, Lavanchy C, et al. Cross-presenting dendritic cells are required for control of Leishmania major infection. Eur J Immunol (2014) 44(5):1422-32. doi:10.1002/eji.201344242
181. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 179(4):1367-71. doi:10.1084/jem.179.4.1367
182. Ray M, Gam AA, Boykins RA, Kenney RT. Inhibition of interferon-gamma signaling by Leishmania donovani. J Infect Dis (2000) 181(3):1121-8. doi:10.1086/315330
183. Thiakaki M, Kolli B, Chang KP, Soteriadou K. Down-regulation of gp63 level in Leishmania amazonensis promastigotes reduces their infectivity in BALB/c mice. Microbes Infect (2006) 8(6):1455-63. doi:10.1016/j.micinf.2006.01.006
184. Cordeiro-Da-Silva A, Borges MC, Guilvard E, Ouaissi A. Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation. Infect Immun (2001) 69(11):6588-96. doi:10.1128/IAI.69.11.6588-6596.2001
185. Ji J, Masterson J, Sun J, Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol (2005) 174(11):7147-53. doi:10.4049/jimmunol.174.11.7147
186. Gupta G, Majumdar S, Adhikari A, Bhattacharya P, Mukherjee AK, Majumdar SB, et al. Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice. Med Microbiol Immunol (2011) 200(4):241-53. doi:10.1007/s00430-011-0197-y
187. Martin S, Agarwal R, Murugaiyan G, Saha B. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection. J Immunol (2010) 185(1):551-9. doi:10.4049/jimmunol.0902206
188. Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 200(2):201-10. doi:10.1084/jem.20040298
189. Ehrlich A, Moreno Castilho T, Goldsmith-Pestana K, Chae WJ, Bothwell AL, Sparwasser T, et al. The Immunotherapeutic Role of Regulatory T Cells in Leishmania (Viannia) panamensis Infection. J Immunol (2014) 193(6):2961-70. doi:10.4049/jimmunol.1400728
190. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med (2007) 204(4):805-17. doi:10.1084/jem.20061141
191. Okwor I, Uzonna J. Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. Immunol Res (2008) 41(2):123-36. doi:10.1007/s12026-008-8016-2
192. Murray HW, Lu CM, Mauze S, Freeman S, Moreira AL, Kaplan G, et al. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun (2002) 70(11):6284-93. doi:10.1128/IAI.70.11.6284-6293.2002
193. Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol (2001) 31(10):2848-56. doi:10.1002/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.3.CO;2-K
194. Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 204(2):285-97. doi:10.1084/jem.20061886
195. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 420(6915):502-7. doi:10.1038/nature01152
196. Brelaz MC, de Oliveira AP, de Almeida AF, de Assis Souza M, Medeiros AC, de Brito ME, et al. Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease. Parasite Immunol (2012) 34(4):236-9. doi:10.1111/j.1365-3024.2012.01351.x
197. Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol (2007) 179(8):5592-603. doi:10.4049/jimmunol.179.8.5592
198. Owens BM, Beattie L, Moore JW, Brown N, Mann JL, Dalton JE, et al. IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c(+) cell populations during visceral leishmaniasis. PLoS Pathog (2012) 8(7):e1002827. doi:10.1371/journal.ppat.1002827
199. Pagan AJ, Peters NC, Debrabant A, Ribeiro-Gomes F, Pepper M, Karp CL, et al. Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice. Eur J Immunol (2013) 43(2):427-38. doi:10.1002/eji.201242715
200. Resende M, Moreira D, Augusto J, Cunha J, Neves B, Cruz MT, et al. Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-gamma+ IL-10+ phenotype. J Immunol (2013) 191(1):262-73. doi:10.4049/jimmunol.1203518
201. Gomes CM, Avila LR, Pinto SA, Duarte FB, Pereira LI, Abrahamsohn IA, et al. Leishmania braziliensis amastigotes stimulate production of IL-1beta, IL-6, IL-10 and TGF-beta by peripheral blood mononuclear cells from nonendemic area healthy residents. Parasite Immunol (2014) 36(5):225-31. doi:10.1111/pim.12109
202. Padigel UM, Farrell JP. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol (2005) 174(10):6340-5. doi:10.4049/jimmunol.174.10.6340
203. Yang Z, Mosser DM, Zhang X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol (2007) 178(2):1077-85. doi:10.4049/jimmunol.178.2.1077
204. Buxbaum LU. Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans. PLoS Negl Trop Dis (2013) 7(5):e2224. doi:10.1371/journal.pntd.0002224
205. Santarem N, Silvestre R, Tavares J, Silva M, Cabral S, Maciel J, et al. Immune response regulation by Leishmania secreted and nonsecreted antigens. J Biomed Biotechnol (2007) 2007(6):85154. doi:10.1155/2007/85154
206. Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, et al. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol (2000) 164(9):4819-25. doi:10.4049/jimmunol.164.9.4819
207. Tabatabaee PA, Abolhassani M, Mahdavi M, Nahrevanian H, Azadmanesh K. Leishmania major: secreted antigens of Leishmania major promastigotes shift the immune response of the C57BL/6 mice toward Th2 in vitro. Exp Parasitol (2011) 127(1):46-51. doi:10.1016/j.exppara.2010.06.033
208. Chakour R, Allenbach C, Desgranges F, Charmoy M, Mauel J, Garcia I, et al. A new function of the Fas-FasL pathway in macrophage activation. J Leukoc Biol (2009) 86(1):81-90. doi:10.1189/jlb.1008590
209. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med (2000) 192(6):823-33. doi:10.1084/jem.192.6.823
210. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol (2001) 2(11):1054-60. doi:10.1038/ni725
211. Hurdayal R, Nieuwenhuizen NE, Revaz-Breton M, Smith L, Hoving JC, Parihar SP, et al. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection. PLoS Pathog (2013) 9(10):e1003699. doi:10.1371/journal.ppat.1003699
212. Uzonna JE, Joyce KL, Scott P. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med (2004) 199(11):1559-66. doi:10.1084/jem.20040172
213. Maia C, Seblova V, Sadlova J, Votypka J, Volf P. Experimental transmission of Leishmania infantum by two major vectors: a comparison between a viscerotropic and a dermotropic strain. PLoS Negl Trop Dis (2011) 5(6):e1181. doi:10.1371/journal.pntd.0001181
214. Bacellar O, Faria D, Nascimento M, Cardoso TM, Gollob KJ, Dutra WO, et al. Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis (2009) 200(1):75-8. doi:10.1086/599380
215. Katara GK, Ansari NA, Singh A, Ramesh V, Salotra P. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL). PLoS Negl Trop Dis (2012) 6(6):e1703. doi:10.1371/journal.pntd.0001703
216. Soong L, Henard CA, Melby PC. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis. Semin Immunopathol (2012) 34(6):735-51. doi:10.1007/s00281-012-0350-8
217. Castellano LR, Llaguno M, Silva MV, Machado JR, Correia D, Silva-Vergara ML, et al. Immunophenotyping of circulating T cells in a mucosal leishmaniasis patient coinfected with HIV. Rev Soc Bras Med Trop (2011) 44(4):520-1. doi:10.1590/S0037-86822011000400025
218. Ghosh K, Sharma G, Saha A, Kar S, Das PK, Ukil A. Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. J Infect Dis (2013) 207(6):1016-25. doi:10.1093/infdis/jis771
219. Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest (2009) 119(8):2379-87. doi:10.1172/JCI38813
220. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe (2009) 5(5):487-97. doi:10.1016/j.chom.2009.05.002
221. Lefevre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D, Authier H, et al. The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity (2013) 38(5):1038-49. doi:10.1016/j.immuni.2013.04.010
222. Ansari NA, Kumar R, Gautam S, Nylen S, Singh OP, Sundar S, et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol (2011) 186(7):3977-85. doi:10.4049/jimmunol.1003588
223. Santangeli L, McCluney NA, Hathorn I, Shakeel M, Anderson C. Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness. J Laryngol Otol (2009) 123(10):1181-3. doi:10.1017/S0022215109004216
224. Nigg AP, Zahn S, Ruckerl D, Holscher C, Yoshimoto T, Ehrchen JM, et al. Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J Immunol (2007) 178(11):7251-8. doi:10.4049/jimmunol.178.11.7251
225. Hurdayal R, Brombacher F. The role of IL-4 and IL-13 in cutaneous Leishmaniasis. Immunol Lett (2014) 161(2):179-83. doi:10.1016/j.imlet.2013.12.022
226. Kaye PM. Costimulation and the regulation of antimicrobial immunity. Immunol Today (1995) 16(9):423-7. doi:10.1016/0167-5699(95)80018-2
227. Overath P, Aebischer T. Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol Today (1999) 15(8):325-32. doi:10.1016/S0169-4758(99)01473-8
228. Locksley RM, Reiner SL, Hatam F, Littman DR, Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science (1993) 261(5127):1448-51. doi:10.1126/science.8367726
229. Reiner NE, Ng W, McMaster WR. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol (1987) 138(6):1926-32.
230. Muraille E, De Trez C, Pajak B, Torrentera FA, De Baetselier P, Leo O, et al. Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major. Infect Immun (2003) 71(5):2704-15. doi:10.1128/IAI.71.5.2704-2715.2003
231. Prina E, Abdi SZ, Lebastard M, Perret E, Winter N, Antoine JC. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci (2004) 117(Pt 2):315-25. doi:10.1242/jcs.00860
232. Bennett CL, Colledge L, Richards HE, Reay PA, Blackburn CC, Aebischer T. Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells. Eur J Immunol (2003) 33(12):3504-13. doi:10.1002/eji.200323425
233. Antoine JC, Lang T, Prina E, Courret N, Hellio R. H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana. J Cell Sci (1999) 112(Pt 15):2559-70.
234. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I, et al. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol (2010) 185(9):5011-22. doi:10.4049/jimmunol.1000541
235. Kima PE, Soong L, Chicharro C, Ruddle NH, McMahon-Pratt D. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J Immunol (1996) 26(12):3163-9. doi:10.1002/eji.1830261249
236. Prina E, Jouanne C, de Souza Lao S, Szabo A, Guillet JG, Antoine JC. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol (1993) 151(4):2050-61.
237. Meier CL, Svensson M, Kaye PM. Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level. J Immunol (2003) 171(12):6706-13. doi:10.4049/jimmunol.171.12.6706
238. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol (2005) 175(5):3214-24. doi:10.4049/jimmunol.175.5.3214
239. Majumder S, Dey R, Bhattacharjee S, Rub A, Gupta G, Bhattacharyya Majumdar S, et al. Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite. J Infect Dis (2012) 205(10):1607-16. doi:10.1093/infdis/jis229
240. Bimal S, Singh SK, Sinha S, Pandey K, Sinha PK, Ranjan A, et al. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis. Exp Parasitol (2008) 118(2):238-46. doi:10.1016/j.exppara.2007.08.009
241. Kaye PM, Rogers NJ, Curry AJ, Scott JC. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol (1994) 24(11):2850-4. doi:10.1002/eji.1830241140
242. Mbow ML, DeKrey GK, Titus RG. Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol (2001) 31(5):1400-9. doi:10.1002/1521-4141(200105)31:5<1400::AID-IMMU1400>3.0.CO;2-J
243. Neves BM, Silvestre R, Resende M, Ouaissi A, Cunha J, Tavares J, et al. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol (2010) 177(6):2898-911. doi:10.2353/ajpath.2010.100367
244. Favali C, Tavares N, Clarencio J, Barral A, Barral-Netto M, Brodskyn C. Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leukoc Biol (2007) 82(6):1401-6. doi:10.1189/jlb.0307187
245. Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol (2010) 11(1):21-7. doi:10.1038/ni.1817
246. Gautam S, Kumar R, Singh N, Singh AK, Rai M, Sacks D, et al. CD8 T cell exhaustion in human visceral leishmaniasis. J Infect Dis (2014) 209(2):290-9. doi:10.1093/infdis/jit401
247. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol (2004) 4(5):336-47. doi:10.1038/nri1349
248. Esch KJ, Juelsgaard R, Martinez PA, Jones DE, Petersen CA. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J Immunol (2013) 191(11):5542-50. doi:10.4049/jimmunol.1301810
249. Rodrigues V, Cordeiro-da-Silva A, Laforge M, Ouaissi A, Akharid K, Silvestre R, et al. Impairment of T cell function in parasitic infections. PLoS Negl Trop Dis (2014) 8(2):e2567. doi:10.1371/journal.pntd.0002567